They selected insulin-like growth factor-binding protein 6 (IGFBP6), vimentin (VIM) and acrogranin (GRN) as proteins potentially implicated in the CRC progression and validated them by Western blot, ELISA and immunofluorescence (Table 2). Here, GRN is linked to colorectal carcinoma.